107 related articles for article (PubMed ID: 34251833)
1. Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.
Masuda R; Lodge S; Nitschke P; Spraul M; Schaefer H; Bong SH; Kimhofer T; Hall D; Loo RL; Bizkarguenaga M; Bruzzone C; Gil-Redondo R; Embade N; Mato JM; Holmes E; Wist J; Millet O; Nicholson JK
J Proteome Res; 2021 Aug; 20(8):4139-4152. PubMed ID: 34251833
[TBL] [Abstract][Full Text] [Related]
2. NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines.
Lodge S; Nitschke P; Kimhofer T; Coudert JD; Begum S; Bong SH; Richards T; Edgar D; Raby E; Spraul M; Schaefer H; Lindon JC; Loo RL; Holmes E; Nicholson JK
J Proteome Res; 2021 Feb; 20(2):1382-1396. PubMed ID: 33426894
[TBL] [Abstract][Full Text] [Related]
3. Low Volume in Vitro Diagnostic Proton NMR Spectroscopy of Human Blood Plasma for Lipoprotein and Metabolite Analysis: Application to SARS-CoV-2 Biomarkers.
Lodge S; Nitschke P; Loo RL; Kimhofer T; Bong SH; Richards T; Begum S; Spraul M; Schaefer H; Lindon JC; Holmes E; Nicholson JK
J Proteome Res; 2021 Feb; 20(2):1415-1423. PubMed ID: 33491459
[TBL] [Abstract][Full Text] [Related]
4. Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection.
Kimhofer T; Lodge S; Whiley L; Gray N; Loo RL; Lawler NG; Nitschke P; Bong SH; Morrison DL; Begum S; Richards T; Yeap BB; Smith C; Smith KGC; Holmes E; Nicholson JK
J Proteome Res; 2020 Nov; 19(11):4442-4454. PubMed ID: 32806897
[TBL] [Abstract][Full Text] [Related]
5. Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients.
Berezhnoy G; Bissinger R; Liu A; Cannet C; Schäfer H; Kienzle K; Bitzer M; Häberle H; Göpel S; Trautwein C; Singh Y
Front Immunol; 2023; 14():1144224. PubMed ID: 37228606
[TBL] [Abstract][Full Text] [Related]
6. Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction.
Lodge S; Lawler NG; Gray N; Masuda R; Nitschke P; Whiley L; Bong SH; Yeap BB; Dwivedi G; Spraul M; Schaefer H; Gil-Redondo R; Embade N; Millet O; Holmes E; Wist J; Nicholson JK
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511373
[TBL] [Abstract][Full Text] [Related]
7. Diffusion and Relaxation Edited Proton NMR Spectroscopy of Plasma Reveals a High-Fidelity Supramolecular Biomarker Signature of SARS-CoV-2 Infection.
Lodge S; Nitschke P; Kimhofer T; Wist J; Bong SH; Loo RL; Masuda R; Begum S; Richards T; Lindon JC; Bermel W; Reinsperger T; Schaefer H; Spraul M; Holmes E; Nicholson JK
Anal Chem; 2021 Mar; 93(8):3976-3986. PubMed ID: 33577736
[TBL] [Abstract][Full Text] [Related]
8. Exploration of Human Serum Lipoprotein Supramolecular Phospholipids Using Statistical Heterospectroscopy in
Masuda R; Lodge S; Whiley L; Gray N; Lawler N; Nitschke P; Bong SH; Kimhofer T; Loo RL; Boughton B; Zeng AX; Hall D; Schaefer H; Spraul M; Dwivedi G; Yeap BB; Diercks T; Bernardo-Seisdedos G; Mato JM; Lindon JC; Holmes E; Millet O; Wist J; Nicholson JK
Anal Chem; 2022 Mar; 94(10):4426-4436. PubMed ID: 35230805
[TBL] [Abstract][Full Text] [Related]
9. Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome.
Holmes E; Wist J; Masuda R; Lodge S; Nitschke P; Kimhofer T; Loo RL; Begum S; Boughton B; Yang R; Morillon AC; Chin ST; Hall D; Ryan M; Bong SH; Gay M; Edgar DW; Lindon JC; Richards T; Yeap BB; Pettersson S; Spraul M; Schaefer H; Lawler NG; Gray N; Whiley L; Nicholson JK
J Proteome Res; 2021 Jun; 20(6):3315-3329. PubMed ID: 34009992
[TBL] [Abstract][Full Text] [Related]
10. Quantitative In-Vitro Diagnostic NMR Spectroscopy for Lipoprotein and Metabolite Measurements in Plasma and Serum: Recommendations for Analytical Artifact Minimization with Special Reference to COVID-19/SARS-CoV-2 Samples.
Loo RL; Lodge S; Kimhofer T; Bong SH; Begum S; Whiley L; Gray N; Lindon JC; Nitschke P; Lawler NG; Schäfer H; Spraul M; Richards T; Nicholson JK; Holmes E
J Proteome Res; 2020 Nov; 19(11):4428-4441. PubMed ID: 32852212
[TBL] [Abstract][Full Text] [Related]
11. Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients.
Ghini V; Meoni G; Pelagatti L; Celli T; Veneziani F; Petrucci F; Vannucchi V; Bertini L; Luchinat C; Landini G; Turano P
PLoS Pathog; 2022 Apr; 18(4):e1010443. PubMed ID: 35446921
[TBL] [Abstract][Full Text] [Related]
12. Cross-Validation of Metabolic Phenotypes in SARS-CoV-2 Infected Subpopulations Using Targeted Liquid Chromatography-Mass Spectrometry (LC-MS).
Whiley L; Lawler NG; Zeng AX; Lee A; Chin ST; Bizkarguenaga M; Bruzzone C; Embade N; Wist J; Holmes E; Millet O; Nicholson JK; Gray N
J Proteome Res; 2024 Apr; 23(4):1313-1327. PubMed ID: 38484742
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients.
Schmelter F; Föh B; Mallagaray A; Rahmöller J; Ehlers M; Lehrian S; von Kopylow V; Künsting I; Lixenfeld AS; Martin E; Ragab M; Meyer-Saraei R; Kreutzmann F; Eitel I; Taube S; Käding N; Jantzen E; Graf T; Sina C; Günther UL
Front Mol Biosci; 2021; 8():737039. PubMed ID: 34938772
[TBL] [Abstract][Full Text] [Related]
14. Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses.
Lawler NG; Gray N; Kimhofer T; Boughton B; Gay M; Yang R; Morillon AC; Chin ST; Ryan M; Begum S; Bong SH; Coudert JD; Edgar D; Raby E; Pettersson S; Richards T; Holmes E; Whiley L; Nicholson JK
J Proteome Res; 2021 May; 20(5):2796-2811. PubMed ID: 33724837
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort.
Davidson N; Evans J; Giammichele D; Powell H; Hobson P; Teis B; Glover H; Guppy-Coles KB; Robson J
Pathology; 2020 Dec; 52(7):764-769. PubMed ID: 33070955
[TBL] [Abstract][Full Text] [Related]
16. Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients.
Martín-Sánchez E; Garcés JJ; Maia C; Inogés S; López-Díaz de Cerio A; Carmona-Torre F; Marin-Oto M; Alegre F; Molano E; Fernandez-Alonso M; Perez C; Botta C; Zabaleta A; Alcaide AB; Landecho MF; Rua M; Pérez-Warnisher T; Blanco L; Sarvide S; Vilas-Zornoza A; Alignani D; Moreno C; Pineda I; Sogbe M; Argemi J; Paiva B; Yuste JR
Front Immunol; 2021; 12():659018. PubMed ID: 34012444
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID-19.
Myhre PL; Prebensen C; Jonassen CM; Berdal JE; Omland T
J Am Heart Assoc; 2021 May; 10(9):e019756. PubMed ID: 33596668
[TBL] [Abstract][Full Text] [Related]
18. Identification of Immune Activation Markers in the Early Onset of COVID-19 Infection.
Kovarik JJ; Kämpf AK; Gasser F; Herdina AN; Breuer M; Kaltenecker CC; Wahrmann M; Haindl S; Mayer F; Traby L; Touzeau-Roemer V; Grabmeier-Pfistershammer K; Kussmann M; Robak O; Willschke H; Ay C; Säemann MD; Schmetterer KG; Strassl R
Front Cell Infect Microbiol; 2021; 11():651484. PubMed ID: 34540715
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Snapshot of Plasma Samples Reveals New Pathways Implicated in SARS-CoV-2 Pathogenesis.
Albóniga OE; Jiménez D; Sánchez-Conde M; Vizcarra P; Ron R; Herrera S; Martínez-Sanz J; Moreno E; Moreno S; Barbas C; Serrano-Villar S
J Proteome Res; 2022 Mar; 21(3):623-634. PubMed ID: 35133846
[TBL] [Abstract][Full Text] [Related]
20. Stratification of hypertension and SARS-CoV-2 infection by quantitative NMR spectroscopy of human blood serum.
Kazenwadel J; Berezhnoy G; Cannet C; Schäfer H; Geisler T; Rohlfing AK; Gawaz M; Merle U; Trautwein C
Commun Med (Lond); 2023 Oct; 3(1):145. PubMed ID: 37845506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
